Article
Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Cancer research - 15 Dec 2005
Chen Yen-Ching, Giovannucci Edward, Lazarus Ross, Kraft Peter, Ketkar Shamika, Hunter David J
Abstract excerpt
Chronic inflammation has been hypothesized to be a risk factor for prostate cancer. The Toll-like receptor 4 (TLR4) presents the bacterial lipopolysaccharide (LPS), which interacts with ligand-binding protein and CD14 (LPS receptor) and activates expression of inflammatory genes through nuclear factor-kappaB and mitogen-activated protein kinase signaling. A previous case-control study found a modest association...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
